Skip to main content

Bone/OP&OA

List.jpg
These were my top abstracts from Thursday, 4th of June at EULAR 2020: Long Delays in Denosumab Increase Fracture Risk (SAT0453).  A UK population based study looked at risk of fracture in adults…
Analysis of the UK THIN database shows that delays in receiving followup Denosumab injx results in higher fracture risk

Dr. John Cush RheumNow

1 month 4 weeks ago
Analysis of the UK THIN database shows that delays in receiving followup Denosumab injx results in higher fracture risk (vertebral & Maj OP Fx). 6144 infusions in 2594 pts, shows risk if delay is >16wks (long delay), but not if 4-16wks #EULAR20 SAT0453 https://t.co/DkJK3dHeRN https://t.co/r7ckpSF6PA
Yet another NEGATIVE Trial in Hand OA. Add Hand OA to the list that Includes Scleroderma, Sjogrens and CRPS as untreatab

Dr. John Cush RheumNow

2 months ago
Yet another NEGATIVE Trial in Hand OA. Add Hand OA to the list that Includes Scleroderma, Sjogrens and CRPS as untreatable diseases with large unmet needs! https://t.co/cMMqmeo19N
×